Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · IEX Real-Time Price · USD
6.35
+0.13 (2.09%)
At close: Jul 19, 2024, 4:00 PM
6.31
-0.04 (-0.63%)
Pre-market: Jul 22, 2024, 5:05 AM EDT
Titan Pharmaceuticals Revenue
Titan Pharmaceuticals had revenue of $87.00K in the twelve months ending March 31, 2024. In the year 2023, Titan Pharmaceuticals had annual revenue of $184.00K.
Revenue (ttm)
$87.00K
Revenue Growth
-81.25%
P/S Ratio
66.73
Revenue / Employee
$21,750
Employees
4
Market Cap
5.81M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 184.00K | -373.00K | -66.97% |
Dec 31, 2022 | 557.00K | -969.00K | -63.50% |
Dec 31, 2021 | 1.53M | -3.31M | -68.46% |
Dec 31, 2020 | 4.84M | 2.23M | 85.72% |
Dec 31, 2019 | 2.61M | -4.01M | -60.64% |
Dec 31, 2018 | 6.62M | 6.40M | 2,978.14% |
Dec 31, 2017 | 215.00K | -14.85M | -98.57% |
Dec 31, 2016 | 15.07M | 13.39M | 801.56% |
Dec 31, 2015 | 1.67M | -1.98M | -54.17% |
Dec 31, 2014 | 3.65M | -6.84M | -65.21% |
Dec 31, 2013 | 10.48M | 3.36M | 47.27% |
Dec 31, 2012 | 7.12M | 3.05M | 74.95% |
Dec 31, 2011 | 4.07M | -6.03M | -59.69% |
Dec 31, 2010 | 10.09M | 10.01M | 12,675.95% |
Dec 31, 2009 | 79.00K | 6.00K | 8.22% |
Dec 31, 2008 | 73.00K | 49.00K | 204.17% |
Dec 31, 2007 | 24.00K | -8.00K | -25.00% |
Dec 31, 2006 | 32.00K | -57.00K | -64.04% |
Dec 31, 2005 | 89.00K | 58.00K | 187.10% |
Dec 31, 2004 | 31.00K | -58.00K | -65.17% |
Dec 31, 2003 | 89.00K | -2.80M | -96.92% |
Dec 31, 2002 | 2.89M | -1.68M | -36.75% |
Dec 31, 2001 | 4.57M | 2.69M | 143.19% |
Dec 31, 2000 | 1.88M | 1.54M | 457.86% |
Dec 31, 1999 | 337.00K | - | - |
Dec 31, 1998 | 0 | - | - |
Dec 31, 1997 | 17.50M | 17.24M | 6,661.67% |
Dec 31, 1996 | 258.81K | 119.29K | 85.50% |
Dec 31, 1995 | 139.52K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sonoma Pharmaceuticals | 12.74M |
Biomerica | 5.41M |
TFF Pharmaceuticals | 885.72K |
Soligenix | 699.21K |
Oragenics | 20.63K |
Ainos | -28.44K |
TTNP News
- 6 months ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 7 months ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 9 months ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 11 months ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Provides Shareholder Update - GlobeNewsWire
- 1 year ago - UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. - GlobeNewsWire
- 2 years ago - Titan Pharmaceuticals Announces Board Expansion and Management Changes - PRNewsWire